Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era

Author:

Barnard Rosanna C.ORCID,Davies Nicholas G.ORCID,Munday James D.,Lowe Rachel,Knight Gwenan M.,Leclerc Quentin J.,Tully Damien C.,Hodgson David,Pung Rachael,Hellewell Joel,Koltai Mihaly,Simons David,Abbas Kaja,Kucharski Adam J.,Procter Simon R.,Sandmann Frank G.,Pearson Carl A. B.,Prem Kiesha,Showering Alicia,Meakin Sophie R.,O’Reilly Kathleen,McCarthy Ciara V.,Quaife Matthew,Wong Kerry L. M.,Jafari Yalda,Deol Arminder K.,Houben Rein M. G. J.,Diamond Charlie,Jombart Thibaut,Villabona-Arenas C. Julian,Waites William,Eggo Rosalind M.,Endo Akira,Gibbs Hamish P.,Klepac Petra,Williams Jack,Quilty Billy J.,Brady Oliver,Emery Jon C.,Atkins Katherine E.,Chapman Lloyd A. C.,Sherratt Katharine,Abbott Sam,Bosse Nikos I.,Mee Paul,Funk Sebastian,Lei Jiayao,Liu Yang,Flasche Stefan,Rudge James W.,Sun Fiona Yueqian,Medley Graham,Russell Timothy W.,Gimma Amy,Hué Stéphane,Jarvis Christopher I.,Finch Emilie,Clifford Samuel,Jit MarkORCID,Edmunds W. JohnORCID,

Abstract

AbstractEngland has experienced a heavy burden of COVID-19, with multiple waves of SARS-CoV-2 transmission since early 2020 and high infection levels following the emergence and spread of Omicron variants since late 2021. In response to rising Omicron cases, booster vaccinations were accelerated and offered to all adults in England. Using a model fitted to more than 2 years of epidemiological data, we project potential dynamics of SARS-CoV-2 infections, hospital admissions and deaths in England to December 2022. We consider key uncertainties including future behavioural change and waning immunity and assess the effectiveness of booster vaccinations in mitigating SARS-CoV-2 disease burden between October 2021 and December 2022. If no new variants emerge, SARS-CoV-2 transmission is expected to decline, with low levels remaining in the coming months. The extent to which projected SARS-CoV-2 transmission resurges later in 2022 depends largely on assumptions around waning immunity and to some extent, behaviour, and seasonality.

Funder

European Commission

RCUK | Medical Research Council

DH | National Institute for Health Research

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Reference67 articles.

1. COVID-19 Data Explorer. Our World in Data https://ourworldindata.org/coronavirus-data-explorer.

2. UK Summary. https://coronavirus.data.gov.uk.

3. Tracking SARS-CoV-2 variants. https://www.who.int/activities/tracking-SARS-CoV-2-variants.

4. Website. https://www.instituteforgovernment.org.uk/charts/uk-government-coronavirus-lockdowns.

5. Prime Minister’s Office,. PM statement on living with COVID: 21 February 2022. GOV.UK https://www.gov.uk/government/speeches/pm-statement-on-living-with-covid-21-february-2022 (2022).

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3